Becker's Healthcare June 18, 2024
On June 17, Merck received FDA approval for a vaccine designed to protect adults from pneumococcus, a type of bacteria that can cause serious disease, including pneumonia.
The conjugate vaccine, called Capvaxive, is meant to protect against 21 strains of the bacteria that most often cause invasive pneumococcal disease in...